Abstract

Both plasma and cerebrospinal fluid (CSF) are rich in cholesterol and its metabolites. Here we describe in detail a methodology for the identification and quantification of multiple sterols including oxysterols and sterol-acids found in these fluids. The method is translatable to any laboratory with access to liquid chromatography – tandem mass spectrometry. The method exploits isotope-dilution mass spectrometry for absolute quantification of target metabolites. The method is applicable for semi-quantification of other sterols for which isotope labelled surrogates are not available and approximate quantification of partially identified sterols. Values are reported for non-esterified sterols in the absence of saponification and total sterols following saponification. In this way absolute quantification data is reported for 17 sterols in the NIST SRM 1950 plasma along with semi-quantitative data for 8 additional sterols and approximate quantification for one further sterol. In a pooled (CSF) sample used for internal quality control, absolute quantification was performed on 10 sterols, semi-quantification on 9 sterols and approximate quantification on a further three partially identified sterols. The value of the method is illustrated by confirming the sterol phenotype of a patient suffering from ACOX2 deficiency, a rare disorder of bile acid biosynthesis, and in a plasma sample from a patient suffering from cerebrotendinous xanthomatosis, where cholesterol 27-hydroxylase is deficient.

Highlights

  • Plasma/serum and cerebrospinal fluid (CSF) represent body fluids widely studied with an ultimate goal of revealing biomarkers of disease [1,2,3,4,5,6,7]

  • Most of the GP-derivatised monohydroxycholesterols (HC) targeted by the OxysterolSPLASH mix are chromatographically separated by the 17 min and 37 min gradients (Figure 2)

  • We have previously shown that using the Enzyme-assisted derivatisation for sterol analysis (EADSA) approach [2H6]24R/SHC can be used as a reasonable surrogate for side-chain mono-hydroxycholesterols and other oxysterols [26]

Read more

Summary

Introduction

Plasma/serum and cerebrospinal fluid (CSF) represent body fluids widely studied with an ultimate goal of revealing biomarkers of disease [1,2,3,4,5,6,7]. A second challenge for the inter-laboratory comparison of quantitative data is provided by the variation in the exact nature of the samples analysed and compared This problem can be overcome by the use of well documented Standard Reference. 5 other sterols were presumptively identified in the absence of authentic standards but not quantified It should be noted, that besides the sterols reported here in the SRM plasma and QC CSF, a very large number of additional oxysterols and sterol-acids have been detected in samples from patients suffering from inborn errors of sterol metabolism, which are quantitatively minor in samples from healthy individuals [24,25,26,27,28].

Materials
Plasma - OxysterolSPLASH
Plasma - Quantitative isotope-labelled standards
CSF - OxysterolSPLASH
CSF - Quantitative isotope-labelled standards
Non-esterified sterols including oxysterols and sterol-acids in plasma
Esterified oxysterols in plasma
Quantification
Optimal amounts and reproducibility
Comparison of data for esterified and non-esterified sterols
Sterols including oxysterols and sterol-acids in CSF
Non-esterified sterols including oxysterols and sterol-acids in CSF
Esterified sterols and oxysterols in CSF
Quantification of oxysterols in patient samples
Discussion
Declaration of interests
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call